AbbVie ($ABBV) Insider Trading & Smart Money Activity
AbbVie Inc. ($ABBV) has 2 congress trades, 219 13F position changes and 8 analyst ratings on file.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 2
- 13F moves on file
- 219
- Analyst ratings on file
- 8
ABBV insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 1 / 0 | 2 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 112 / 86 |
| Q3 2026 | 0 | 0 | 0 / 1 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 8 / 11 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All ABBV insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | Y-Intercept (Hong Kong) | Sold out | -74.25K sh | Read | |||||||
| 13F | DiNuzzo Private Wealth | Added | +100 sh | $154.18K | — | ||||||
| 13F | Cardinal Capital Management | Reduced | -28.52K sh | $64.14M | — | ||||||
| 13F | Cantor Fitzgerald Investment Advisors L.P. | Reduced | -2.45K sh | $640.90K | — | ||||||
| 13F | Cache Advisors | Added | +11.35K sh | $5.68M | — | ||||||
| 13F | Banque Pictet & Cie | Reduced | -33.79K sh | $98.24M | — | ||||||
| 13F | Zwj Investment Counsel | Reduced | -6.90K sh | $87.51M | Read | ||||||
| 13F | V-Square Quantitative Management | Added | +1.26K sh | $3.26M | — | ||||||
| 13F | Patriot Investment Management Group | Added | +668 sh | $1.20M | — | ||||||
| 13F | Mission Wealth Management | Reduced | -19.51K sh | $12.96M | — | ||||||
| 13F | HCR Wealth Advisors | Added | +948 sh | $4M | — | ||||||
| 13F | Guyasuta Investment Advisors | Reduced | -1.29K sh | $7.07M | — | ||||||
| 13F | First Merchants | Reduced | -2.19K sh | $14.90M | — | ||||||
| 13F | Burney Co/ | Added | +9.82K sh | $14.51M | — | ||||||
| 13F | Thurston, Springer, Miller, Herd & Titak | Reduced | -5.32K sh | $477.38K | — | ||||||
| 13F | Patriot Financial Group Insurance Agency | Reduced | -6.72K sh | $2.68M | — | ||||||
| 13F | Moody Lynn Lieberson & Walker | Added | +5.01K sh | $45.51M | — | ||||||
| 13F | Kmg Fiduciary Partners | Reduced | -2.38K sh | $15.88M | Read | ||||||
| 13F | Godsey & Gibb | Added | +1.62K sh | $19.85M | — | ||||||
| Analyst | RBC Capital | Reiterates to Outperform | PT $280 | Read | |||||||
| Analyst | Guggenheim | Reiterates to Buy | PT $288 | +3.9% | Read | ||||||
| Analyst | JP Morgan | Reiterates to Overweight | PT $300 | +4.7% | — | ||||||
| Analyst | Cantor Fitzgerald | Reiterates to Overweight | PT $290 | +4.7% | — | ||||||
| Analyst | Morgan Stanley | Reiterates to Overweight | PT $310 | +4.5% | — | ||||||
| Analyst | Scotiabank | Reiterates to Sector Outperform | PT $320 | +2.9% | — | ||||||
| Congress | Pete Sessions | Sale | $15,001 - $50,000 | +1.0% | +8.3% | Read | |||||
| Analyst | Piper Sandler | Reiterates to buy | PT $298 | +7.2% | +10.2% | Read | |||||
| Analyst | Canaccord Genuity | Reiterates to buy | PT $273 | +7.2% | +10.2% | Read | |||||
| 13F | California State Teachers Retirement System | Reduced | -62.38K sh | $677M | +1.8% | +5.6% | Read | ||||
| 13F | Bank of America | Reduced | -1.89M sh | $6.05B | +1.8% | +5.6% | Read | ||||
| 13F | Bank of America | Reduced | -1.89M sh | $5.44B | +1.8% | +5.6% | Read | ||||
| 13F | Amundi | Added | +247.69K sh | $2.70B | +1.8% | +5.6% | Read | ||||
| 13F | Amundi | Added | +247.69K sh | $2.42B | +1.8% | +5.6% | Read | ||||
| 13F | Zurcher Kantonalbank (Zurich Cantonalbank) | New | +660.58K sh | $166.86M | +2.5% | +5.3% | — | ||||
| Congress | Alan Armstrong | Purchase | $15,001 - $50,000 | -1.3% | -5.0% | +28.2% | — |
Showing 35 of 229 filings (the latest 13F moves are capped at 25; see the institutions below).
1W / 1M / 6M = how ABBV moved from the trade or filing date.
Members of Congress trading ABBV
Institutions moving ABBV (13F)
Analyst ratings on ABBV
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| RBC Capital | Reiterates | Outperform | $280 | Read | ||||
| Guggenheim | Reiterates | Buy | $288 | +3.9% | Read | |||
| JP Morgan | Reiterates | Overweight | $285 → $300 | +4.7% | — | |||
| Cantor Fitzgerald | Reiterates | Overweight | $285 → $290 | +4.7% | — | |||
| Morgan Stanley | Reiterates | Overweight | $296 → $310 | +4.5% | — | |||
| Scotiabank | Reiterates | Sector Outperform | $280 → $320 | +2.9% | — | |||
| Piper Sandler | Reiterates | buy | $298 | +7.2% | +10.2% | Read | ||
| Canaccord Genuity | Reiterates | buy | $273 | +7.2% | +10.2% | Read |
Frequently asked questions
Which members of Congress traded ABBV?
2 disclosed trades by Pete Sessions and Alan Armstrong. The latest was on Sep 14, 2026.
Which institutions changed their ABBV positions?
Recent 13F filers moving the stock include Bank of America, Amundi, Wellington Management Group, Susquehanna International Group and Royal Bank of Canada.
Other drug manufacturers - general stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.